CA
Chanmuganathan Atheena Milagi Pandian
About Chanmuganathan Atheena Milagi Pandian
Data last updated:
Chanmuganathan Atheena Milagi Pandian is a Director at Atheenapandian Private Limited (since 2020) and Director at Biomedourse Private Limited (since 2024). The companies operate in Business Services and Non-Profit Organizations. The largest current company by reported revenue is Atheenapandian Private Limited at ₹38 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Atheenapandian Private Limited U74999TN2020PTC135215 | Director | 24 Apr 2020 | 2020 | ₹38 Lakh (FY 2023) | Active |
 Biomedourse Private Limited U85303TN2024PTC167695 | Director | 18 Feb 2024 | 2024 | Active |
Board colleagues of Chanmuganathan Atheena Milagi Pandian
| Name | DIN | Company | Designation |
|---|---|---|---|
| Atheenamilagipandian Shunmuganathan Arumugasakthi | 08736903 | Atheenapandian Private Limited , Biomedourse Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chanmuganathan Atheena Milagi Pandian
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chanmuganathan Atheena Milagi Pandian
Chanmuganathan Atheena Milagi Pandian currently holds 2 directorships: Atheenapandian Private Limited (Director, since 24 Apr 2020, revenue ₹38 Lakh (FY 2023)); Biomedourse Private Limited (Director, since 18 Feb 2024).
Chanmuganathan Atheena Milagi Pandian was first appointed on 24 Apr 2020 as Director at Atheenapandian Private Limited. The most recent appointment on record is 18 Feb 2024 at Biomedourse Private Limited.
The current boards of Chanmuganathan Atheena Milagi Pandian's companies include Atheenamilagipandian Shunmuganathan Arumugasakthi (Atheenapandian Private Limited).